Fig. 3From: Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to malesMulticolor flow cytometry of peripheral blood mononuclear cells (PBMCs). Significantly higher percentages of monocytes (P = 0.03) and trends toward higher percentages of CD3+/CD4+/CD25hi+/Foxp3+ (P = 0.1) and CD3+/CD4+/CD25+/CD127low+ (P = 0.1) T-reg in male patients compared to femalesBack to article page